Skip to main content
Log in

Limitations of peritoneal lavage with antiseptics in prevention of recurrent colorectal cancer caused by tumor-cell seeding

Experimental study in rats

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: Exfoliated or soiled free malignant cells have serious consequences in patients undergoing gastrointestinal cancer surgery. The present study evaluates the toxicity and efficacy of cytotoxic agents in the prevention of cell seeding and tumor growth in the peritoneal cavity in an experimental model. METHODS: Mtln3 adenocarcinoma cell viability was testedin vitro using the trypan blue exclusion test after incubation with povidone-iodine or chlorhexidine.In vivo, Fischer rats were inoculated with 105 or 106 cells followed by peritoneal lavage with physiological saline, chlorhexidine 0.02 percent, providone-iodine low molecular weight 1 percent or povidone-iodine high molecular weight 1 and 2 percent in different quantities and incubation times. RESULTS: Chlorhexidine 0.02 percent and povidone-iodine low molecular weight 1 percent or high molecular weight 2 percent, killed over 98 percent of 105 or 106 tumor cellsin vitro. Povidone-iodine low molecular weight 1 percent and high molecular weight 2 percent were toxic and lethal when 5 ml were applied in the peritoneal cavity three times for five minutes. Chlorhexidine 0.02 percent applied after inoculation of 105 or 106 cells, reduced the tumor development only to 70 and 80 percent. Application of 5 ml povidone-iodine 1 percent low molecular weightor high molecular weight, three times for one and five minutes, after inoculation of 106 cells did not change the tumor take. However, inhibition of Mtln3 cells to form metastases was observed. When povidone-iodine low molecular weight 1 percent was used three times for one minute after 105 tumor cells were “soiled”, no toxicity was observed and the tumor take was reduced to 30 percent (P<0.05). CONCLUSIONS: Povidone-iodine toxicity proved to be a major issuein vivo. However, povidone-iodine low molecular weight 1 percent was safe when used for short periods and very effective when a limited number of tumor cells was inoculated. The use of cytotoxic agents to prevent recurrent disease caused by tumor cell seeding in patients seems to make sense only when the “inoculum size” of exfoliated or soiled cancer cells is limited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Local recurrence following “curative” surgery for large bowel cancer. I. The overall picture. Br J Surg 1984;71:12–6.

    PubMed  Google Scholar 

  2. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;28;1:1479–82.

    Article  Google Scholar 

  3. Keynes WM. Implantation from the bowel lumen in cancer of the large intestine. Ann Surg 1961;153:357–64.

    PubMed  Google Scholar 

  4. Ambrose NS, MacDonald F, Young J, Thompson H, Keighley MR. Monoclonal antibody and cytological detection of free malignant cells in the peritoneal cavity during resection of colorectal cancer—can monoclonal antibodies do better? Eur J Surg Oncol 1989;15:99–102.

    PubMed  Google Scholar 

  5. Umpleby HC, Fermor B, Symes MO, Williamson RC. Viability of exfoliated colorectal carcinoma cells. Br J Surg 1984;71:659–63.

    PubMed  Google Scholar 

  6. Turnbull RB, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg 1967;166:420–7.

    PubMed  Google Scholar 

  7. Ranbarger KR, Johnston WD, Chang JC. Prognostic significance of surgical perforation of the rectum during abdominoperineal resection for rectal carcinoma. Am J Surg 1982;143:186–8.

    Article  PubMed  Google Scholar 

  8. Slanetz CA Jr. The effect of inadvertent intraoperative perforation on survival and recurrence in colorectal cancer. Dis Colon Rectum 1984;27:792–7.

    PubMed  Google Scholar 

  9. Zirngibl H, Husemann B, Hermanek P. Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 1990;33:610–4.

    PubMed  Google Scholar 

  10. Leather AJ, Kocjan G, Savage F,et al. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum 1994;37:814–9.

    Article  PubMed  Google Scholar 

  11. Wong LS, Morris AG, Fraser IA. The exfoliation of free malignant cells in the peritoneal cavity during resection of colorectal cancer. Surg Oncol 1996;5:115–21.

    PubMed  Google Scholar 

  12. Shepherd NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997;112:1096–102.

    PubMed  Google Scholar 

  13. Hase K, Ueno H, Kuranaga N, Utsunomiya K, Kanabe S, Mochizuki H. Intraperitoneal exfoliated cancer cells in patients with colorectal cancer. Dis Colon Rectum 1998;41:1134–40.

    PubMed  Google Scholar 

  14. Schott A, Vogel I, Krueger U,et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 1998;227:372–9.

    Article  PubMed  Google Scholar 

  15. Hillan K, Nordlinger B, Ballet F, Puts JP, Infante R. The healing of colonic anastomoses after early intraperitoneal chemotherapy: an experimental study in rats. J Surg Res 1988;44:166–71.

    Article  PubMed  Google Scholar 

  16. Speyer JL, Sugarbaker PH, Collins JM, Dedrick RL, Klecker RW Jr, Meyers CE. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res 1981;41:1916–22.

    PubMed  Google Scholar 

  17. Stuntz M, Wilmoth G, Ong J, Stabile B, Stamos M. Use of intraperitoneal 5-fluorouracil and chlorhexidine for prevention of recurrence of perforated colorectal carcinoma in a rat model. Dis Colon Rectum 1997;40:1085–8.

    Article  PubMed  Google Scholar 

  18. Keating JP, Neill M, Hill GL. Sclerosing encapsulating peritonitis after intraperitoneal use of povidone-iodine. Aust N Z J Surg 1997;67:742–4.

    PubMed  Google Scholar 

  19. Basha G, Penninckx F, Mebis J, Filez L, Geboes K, Yap P. Local and systemic effect of intra-operative whole-colon washout with povidone-iodine 5 percent. Br J Surg 1999;86:219–26.

    Article  PubMed  Google Scholar 

  20. McAvinchey DJ, McCollum PT, McElearney NG, Mundinger Jr, Lynch G. Antiseptics in the treatment of bacterial peritonitis in rats. Br J Surg 1983;70:158–60.

    PubMed  Google Scholar 

  21. Kuijpers HC. Is prophylactic abdominal irrigation with polyvinylpyrrolidone iodine (PVPI) safe? Dis Colon Rectum 1985;28:481–3.

    PubMed  Google Scholar 

  22. Neri A, Nicholson GL. Phenotypic drift of metastatic and cell surface properties of mammary adenocarcinoma cell clones during growthin vitro. Int J Cancer 1981;28:731–8.

    PubMed  Google Scholar 

  23. Basha G, Penninckx F, Mebis J, Geboes K, Yap P. Prevention of anastomotic tumor take by on-table colon washout with povidone-iodine. An experimental study in rats. Eur Surg Res 1999;31:202–9.

    Article  PubMed  Google Scholar 

  24. Sindelar WF, Mason R. Intraperitoneal irrigation with povidone-iodine solution for the prevention of intra-abdominal abscesses in the bacterially contaminated abdomen. Surg Gynecol Obstet 1979;148:409–11.

    PubMed  Google Scholar 

  25. MacFarlane SD, Ryan JA Jr. Prevention of wound infection after elective colorectal resection. Am J Surg 1987;154:482–6.

    Article  PubMed  Google Scholar 

  26. Khoo RE, Rothenberger DA, Wong WD, Buls JG, Najarian JS. Tube decompression of the dilated colon. Am J Surg 1988;156:214–6.

    PubMed  Google Scholar 

  27. Umpleby HC, Williamson RC. The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma. Ann R Coll Surg Engl 1984;66:192–4.

    PubMed  Google Scholar 

  28. Basha G, Penninckx F, Geboes K, Yap P. Tumoricidal activity of antiseptics with assessment of cell viability in mice with severe combined immunodeficiency. Tumor Biol 1997;18:213–8.

    Google Scholar 

  29. Sindelar WF, Brower ST, Merkel AB, Takesue EI. Randomised trial of intraperitoneal irrigation with low molecular weight povidone-iodine solution to reduce intraabdominal infectious complications. J Hosp Infect 1985;6(Suppl A):103–14.

    PubMed  Google Scholar 

  30. Goldenheim PD. Intraperitoneal povidone-iodine. JAMA 1989;261:1881–2.

    Article  PubMed  Google Scholar 

  31. Moody-Jones D. Karran SJ. Studies of hepatic tolerance of polyvinylpyrrolidone in the rat. J Hosp Infect 1985;6(Suppl A):205–7.

    PubMed  Google Scholar 

  32. Lawrance RJ, Loizidou M, Cooper AJ, Alexander P, Taylor I. Importance of omentum in the development of intra-abdominal metastases. Br J Surg 1991;78:117–9.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Basha, G., Ghirardi, M., Geboes, K. et al. Limitations of peritoneal lavage with antiseptics in prevention of recurrent colorectal cancer caused by tumor-cell seeding. Dis Colon Rectum 43, 1713–1718 (2000). https://doi.org/10.1007/BF02236856

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02236856

Key words

Navigation